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INTRODUCTION
Infertility is the failure of couples to conceive after
regular intercourse without any contraceptive me-
thod for 12 months. Infertility occurs in about 7-
10% of couples. The cause of infertility from female
factors of around 50%, the rest is a male factor of
20-26%, and 25-30% is idiopathic.1 One of the
therapies for infertile couples is to follow the In-
Vitro Fertilization program (IVF). The success rate
of the IVF programs ranges between 30-40% in all
programs in IVF centers around the world. There
are various factors that influence the success of this
program, the genetic factor (congenital), which is
Abstract
Objective: To compare and determine the differences in the level of
homocysteine in the blood and follicular fluid in infertile women
with and without endometriosis, then analyze the effect of homocys-
teine levels to oocyte quality.
Methods: This study was cross-sectional study. Fifty-nine subjects
following the in-vitro fertilization program are included in the ad-
mission criteria were divided into two equal groups, ie groups of en-
dometriosis and without endometriosis consecutively (consecutive
sampling). Each subject taken from the blood and follicular fluid
then measured the levels of homocystein levels with immuoassay
method. The mean of each group was statistically tested with an in-
dependent t test.
Result: The mean levels of homocysteine in the blood is higher in
the endometriosis group than without endometriosis group and it
was statistically significance (8.34 ± 2.68 vs 6.71 ± 1.56, p=0.007;
95% CI: 0.02417-0.14657). Similarly, the levels of homocysteine in
follicular fluid , the endometriosis group is higher and statistically
significance (6.19 ± 1.67 vs 3.46 ± 1.03; p= 0.000; 95% CI: 0.19310-
0.32353). All oocytes are in good quality in both groups, maturation
grade 3. There is a correlation between the levels of homocysteine
in the blood and follicular fluid in the endometriosis group and as-
sessed with Pearson test, and it found significant (p = 0.002) and the
correlation value 0.553 (moderate correlation strength) and direc-
tion of a positive correlation.
Conclusion: The mean levels of homocysteine in the blood and fol-
licular fluid in infertile women with endometriosis is higher than
without endometriosis and were statistically significantly different.
These homocysteine levels does not affect the quality of oocytes.
There is a positive correlation between the levels of homocysteine in
the blood and follicular fluid in endometriosis group.
[Indones J Obstet Gynecol 2013; 37-2: 92-8]
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Abstrak
Tujuan: Membandingkan dan menentukan perbedaan kadar ho-
mosistein dalam darah dan zalir folikel pada perempuan infertil de-
ngan dan tanpa endometriosis, kemudian menganalisis pengaruh ka-
dar homosistein tersebut dengan mutu oosit.
Metode: Penelitian ini merupakan penelitian potong lintang (cross
sectional). Lima puluh sembilan subjek mengikuti program fertilisasi
in-vitro yang masuk dalam kriteria penerimaan dibagi menjadi dua
kelompok sama besar, yakni kelompok endometriosis dan tanpa en-
dometriosis secara konsekutif (consecutive sampling). Masing-masing
subjek diambil percontoh dari darah dan zalir folikel kemudian diukur
kadar homosisteinnya dengan metode teraimun CMIA. Rerata masing-
masing kelompok diuji statistik dengan uji t independen.
Hasil: Rerata kadar homosistein dalam darah pada kelompok en-
dometriosis lebih tinggi dibandingkan dengan tanpa endometriosis
dan secara statisik berbeda bermakna (8,34 ± 2,68 vs 6,71 ± 1,56,
p=0,007; 95% CI: 0,02417-0,14657). Demikian pula dengan kadar ho-
mosistein dalam zalir folikel, kelompok endometriosis lebih tinggi dan
secara statistik berbeda bermakna (6,19 ± 1,67 vs 3,46 ± 1,03; p=
0,000; 95% CI: 0,19310-0,32353). Semua mutu oosit baik pada kedua
kelompok, yakni derajat 3. Terdapat korelasi antara kadar homosis-
tein di dalam darah dan zalir folikel pada kelompok endometriosis dan
dinilai dengan uji Pearson didapatkan bermakna (p = 0,002) dan nilai
korelasi 0,553 (kekuatan korelasi sedang) dan arah korelasi positif.
Kesimpulan: Rerata kadar homosistein dalam darah dan zalir folikel
pada perempuan infertil dengan endometriosis lebih tinggi diban-
dingkan dengan tanpa endometriosis dan secara statistik berbeda
bermakna. Kadar homosistein ini tidak berpengaruh terhadap mutu
oosit. Terdapat korelasi positif antara kadar homosistein dalam darah
dan zalir folikel pada kelompok endometriosis.
[Maj Obstet Ginekol Indones 2013; 37-1: 92-8]
Kata kunci: endometriosis, homosistein, infertilitas, mutu oosit
Correspondence: Aidrus, Jln. Cipinang Jaya LL no. 21 RT 01/08 Jakarta Timur, Mobile phone 0811180429,
email: aidrus.md@gmail.com
Indones J
92  Aidrus et al Obstet Gynecol
difficult to interventions, and acquired factors that
more likely to intervene and prevent. These factors
are quite important role in the microenvironment
within the ovarian follicle. It is well known, most
of every mature follicle there are oocyte, which
quality of oocytes can give influence to embryos
that will be transfer into the uterus on the IVF pro-
grams.
In the last two decades, homocysteine increas-
ingly attracted the attention of researchers because
of it has a unique role in the process illness.2 Ho-
mocysteine as a product of the methionine cycle
has been known to play an important role in car-
diovascular disease, neurological diseases, and em-
bryology, and also in some diseases in the field of
obstetrics and gynecology.3 Levels of homocysteine
are found increased in several diseases, especially
diseases that involve inflammatory process and
autoimmune diseases.2 The increasing of homocys-
teine levels may lead to increased levels of free ra-
dicals, and it caused imbalance between free radi-
cals and antioxidants. In the field of obstetrics, ho-
mocysteine has a role in the pathophysiology of
preeclampsia disease. Elevated levels of homocys-
teine also can lead to increase the risk of recurrent
miscarriage in early pregnancy.3 Various studies
about important role of homocysteine metabolism
in fertility started much discussed.4,5 In the homo-
cysteine metabolism, it involve micronutrients,
such as vitamin B, folic acid, and pyridoxine act as
co-factors. Some of the compounds between the
metabolism of homocysteine works directly with
synthesis of proteins, DNA synthesis and repair,
and balancing the occurrence of oxidative stress
(OS). These things are important in the process
gametogenesis.4
It has long been understood that endometriosis
is a disease that can trigger inflammation process,
thus allowing the occurrence of elevated levels of
homocysteine in the blood. On the other side, one
of the main complaints of the patients with endo-
metriosis is infertility. Pathophysiology of infertil-
ity in endometriosis has many theoretical bases.
One of them is the presence of reactive oxygen spe-
cies (ROS) that can be trigger oxidative stress that
can impair women’s fertility. Excessive increase in
ROS will increase the incidence of apoptotic cells.
These disorders can be impacted to low oocyte
quality, which leads to lower embrio quality.5
Previous studies have shown an increase in the
levels of homocysteine in the follicles liquid in pa-
tients with endometriosis who are undergoing in
vitro fertilization (IVF), which may affect the qua-
lity embrio.5 However, the levels of homocysteine
in the blood and follicular fluid in infertile women
with endometriosis compare to infertile women
without endometriosis still unknown. Also we
want to know the level of homocysteine that can
impact the oocyte quality in both groups. When the
levels of homocysteine in the blood of women with
endometriosis shows meaningful value, the find-
ings are expected to be added to the parameter oo-
cyte quality in infertile women that participate in
IVF program.
METHODS
This study use a cross-sectional design and the
subjects were recruited from three in vitro fertili-
zation (IVF) centers, the Dr. Cipto Mangunkusumo
General Hospital, Yasmin Kencana clinic, Sam Ma-
rie Wijaya Invasive Clinic, and Sam Marie Basuki
Rahmat (Basra) Mother and Children Hospital.
Subjects were taken by a consecutive sampling bet-
ween 20-40 years old. There were 2 groups in the
study, those with endometriosis and the other
group without endometriosis, each with 29 sub-
jects. Patients included into the endometriosis
group by laparoscopy or laparotomy results, which
found the endometriosis lesions, as well as those
who has never undergone both procedures but
with history, physical examination and ultrasonog-
raphy (USG) suggestive for endometriosis lesion or
disease. When the patients were not matched with
the mentioned criteria, the patients were included
into non-endometriosis group. The exclusion crite-
ria in this study were patients with polycystic ova-
ry syndrome, a history of heart disease, hyperten-
sion, renal disease, autoimmune (such as lupus,
rheumatoid arthritis), and body mass index > 25
kg/m2.
On the day of oocyte retrieval, 3-5 ml of venous
blood and follicular fluid from the largest follicle
was withdrawn from the patient after an informed
consent was given. Moreover, the homocysteine le-
vels were evaluated by immunoassay, the CMIA.
RESULTS
The total number of subjects who participated in
this study was 58 female infertile patients from the
Yasmin Kencana Clinic RSCM (52 subjects), RSIA
Sam Marie Basra (3 subjects), and Clinical Invasive
Vol 37, No 2
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Sam Marie Wijaya (3 subjects). Subjects were re-
cruited by the consecutive method, between March
12, 2012 and October 10, 2012 involved in the IVF
program from each clinic. The oldest patient in the
study was 40 years old and the youngest patient
was 24 years old with the average of 33.79 years
old. The age distribution normality was assessed
by the Kolmogorov-Smirnov normality test and it
was found that the distribution was normal and
similar between both groups.
All subjects in current study have never experi-
enced abortion. The types of infertility in almost all
subjects were primary infertility (98.3%), whilst
only one subject with secondary infertility. The
range of infertility period was 1 to 15 years with
the median of 6 years and the infertility period dis-
tribution curve by the Kolmogorov-Smirnov was
not normal.
In this study, the subjects were divided into two
groups, which are endometriosis and non-endo-
metriosis group. In the group without endometrio-
sis, the cause of infertility includes sperm factor
(31%), idiopathic (10.3%), and tubal factor (8.6%).
The characteristics of the two groups were pro-
vided in Table 1.
On the oocytes retrieval day, homocysteine le-
vels from the blood serum and follicular fluid were
evaluated, and the result were presented in Table
2. More over, the oocytes maturity level was asses-
sed, and it was found that all subjects have the ma-
turity level of 3, which indicate the best oocytes.
Table 2. Mean Plasma Homocysteine Levels and Follicu-
lar Fluid in both Groups.
Homocysteine Levels (μmol/l)
p
Plasma Follicular fluid
Mean  8.34  6.71 <0.001
SD ±2.32 ±1.95
Based on the Shapiro-Wilk normality test, the
distribution of plasma homocysteine levels for non-
endometriosis group was normal, while in endo-
metriosis group it was not normal. Because the
later data distribution was not normal, it was
transformed with log 10, so that both groups have
normal distribution. Thus, the parametric test re-
quirements are fulfilled and the independent t-test
can be conducted. The result shows significant re-
lationship between the types of infertility with
plasma homocysteine levels (p = 0.007; 95% CI:
0,02417-0.14657). Comparison of plasma homo-
cysteine levels in both groups, shown in Table 3.
Table 3. Infertility Group Relationships with Plasma Ho-
mocysteine Levels (μmol/l).
Hcy
level
Infertility group
p
Endometriosis Non-endometriosis
Mean 8.34 6.71 0.007
SD ± 2.68 ± 1.56
Table 1. Comparison of Characteristics of Subjects in the Group with Endometriosis and Infertility without Endometriosis.
Characteristics
Infertility Type
p
With endometriosis
(n = 29)
Without endometriosis
(n = 29)
Age (years) Mean 34 33 0.44
SD ± 4 ± 5
Infertility Type Primary 29 28 0.31
Secondary  0  1
Infertility Period (years) Median  6  6 1.0
Minimum  1  1
Maximum 15 14
Protocol of ovulation stimulation Antagonist 26 29 0.23
Agonist  3  0
Right follicle count Mean  5  8 0.06
SD ± 4 ± 4
Left follicle count Mean  5  8 0.06
SD ± 4 ± 4
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The study results revealed that the average fol-
licular fluid homocysteine level in the group with
endometriosis was higher than the other group.
Comparison of these levels was provided in Table
4. Data distribution based on Shapiro-Wilk test for
the group with endometriosis was not normal.
Therefore, the data was transformed into log 10.
After transformed, it was found that data for both
groups were normal. Furthermore, independent t-
test was performed and found a significant rela-
tionship between the two infertility groups with
homocysteine follicular liquid level (p = 0.000, 95%
CI: 0.19310 - 0.32353)
Table 4. Infertility Group Relationship with Homocyste-
ine Levels Follicular Liquid (μmol/l).
Hcy level Infertility group
p
Endometriosis Non-endometriosis
Mean 6.19 3.46 0.000
SD ± 1.67 ± 1.03
In current study, all subjects in both groups had
a level of oocyte maturity of third degrees. Because
the value of this level was constant, the data was
not available to be tested statistically.
 Kolmogorov-Smirnov test for homocysteine le-
vels distribution in plasma and follicle liquid was
not normal. The data were then transformed with
log 10, resulting in normal data distribution. The
Pearson test was then performed to determine the
correlation of homocysteine levels in plasma and
follicular fluid and gave a significant result (p =
0.000) with correlation value of 0.496 (moderate)
and a positive correlation direction.
Based on Shapiro-Wilk test, the plasma and fol-
licular fluid homocysteine levels in endometriosis
group were not well distributed. Therefore, data
was transformed into log 10. After transformation,
normal data distribution was formed. The Pearson
test revealed a significant correlation (p = 0.002)
between homocysteine levels in plasma and in the
follicular fluid with the correlation value of 0.553
(moderate) and a positive direction.
Based on Shapiro-Wilk test, the plasma and fol-
licular fluid homocysteine levels in non-endome-
triosis group were not well distributed. Therefore,
data was transformed into log 10. After transfor-
mation, normal data distribution was formed. The
Pearson test revealed a not significant correlation
(p = 0.129) between homocysteine levels in plasma
and in the follicular fluid with the correlation value
of 0.288 (weak).
Figure 1. Correlation between Plasma Homocysteine
Levels and Follicle.
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Figure 2. Correlation of Homocysteine Levels in Plasma
and in Follicular Fluid in the Endometriosis Group.
Figure 3. Correlation of Homocysteine Levels in Plasma
and in Follicular Fluid in the non-Endometriosis Group.
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DISCUSSION
The study was conducted to 58 subjects matched
with the inclusion criteria. Subjects were infertile
patients included in the In-Vitro Fertilization (IVF)
program in three places, namely Yasmin Kencana
Clinic RSCM, Sam Marie Wijaya Invasive Clinic, and
Sam Marie Basra Mother and Children Hospital.
Study subjects were recruited consecutively and
then classified into two groups, one group with the
diagnosis of endometriosis and the other group
without endometriosis. In the current study, sub-
jects were included into the endometriosis group
when she has a history of surgery resulted in en-
dometriosis lesion findings. Those with no history
of surgery but has an evidence of endometriosis
lesion from history, physical examination, and ul-
trasound, were also placed in endometriosis group.
Subjects without any complaints related to endo-
metriosis and had no endometriosis lesion finding
in physical and ultrasound examination, were then
put in the non-endometriosis group. The age, type
of infertility, and prolonged infertility, shown an al-
most similar situation in both groups.
Mean comparison between homocysteine
level in plasma and follicular fluid
This study shown that the plasma and follicular
fluid homocysteine level in endometriosis infertili-
ty group was statistically higher and significantly
different than in non-endometriosis infertility
group. It was comparable with the study lead by
Ebisch et al5 that measures thiol compound in fol-
licular fluid in men and women with infertility.
From four thiol compound examined, homocyste-
ine had the most significant difference between
groups. Follicular fluid homocysteine level in infer-
tile women with endometriosis was higher than
those in infertile women caused by idiopathic or
tubal factor. Unfortunately, the homocysteine lev-
els were only measured from follicular fluid, not
from blood plasma. Similarly, the levels of homo-
cysteine in the spermatozoa were also higher in the
infertile group due to male factors. That research
also studied the relationship between homocyste-
ine levels in follicular and ejaculate fluids with em-
bryo quality on third day of culture. The results
shown a negative relationship between the two; a
high homocysteine levels can reduce the embryo
quality.
A homocysteine level can be increased heredi-
tary or acquired. In patients with hyperhomocys-
teinemia, there is a gene mutation causes a defi-
ciency of methyltetrahydrofolic reductase (MTHF
R) and cystationin beta-synthase (CBS) enzymes.6
Acquired high level of homocysteine usually caused
by autoimmune or immune cells disorders, such as
systemic lupus erythematosus, Crohn’s disease,
and other diseases causing chronic inflammation,
such as rheumatoid arthritis (RA), and ulcerative
colitis. High homocysteine level can also be caused
by the lack of the nutrient that metabolize homo-
cysteine compounds, such as folic acid, vitamin B12,
vitamin B2, vitamin B6, and zinc.6,7
As reported previously, endometriosis is a dis-
ease that causes chronic inflammation and immune
cells disruption. The inflammation occurs in the
pelvic cavity by interfering immune cells function
and increasing the number of active macrophages
in the peritoneum, thus increasing the inflamma-
tory mediators, such as growth factors and cytok-
ines.8 Elevated homocysteine levels may also be
caused by micro-environment inflammation that
results in impaired follicular development in the
ovaries.
Effect of homocysteine levels with oocyte
quality
In this study, we also assessed the quality of oocyte
derived from the same follicle, which the homocys-
teine level was measured from the follicular fluid.
Veeck method grade 1, 2, and 3 were used and
shown a similar quality from both groups, 3rd de-
gree (good quality), regardless the levels of homo-
cysteine in the plasma and in follicular fluid. Ho-
mocysteine level in the follicular fluid was reported
previously as a parameter of oocytes quality, em-
bryo quality, and the success of pregnancy. High
homocysteine level can cause oxidative stress and
damage the oocyte, giving a poor quality of oocytes,
which furthermore leading to decrease embryo
quality and ultimately lower the pregnancy suc-
cess. This was already proved by studies from
Barker, Boxmeer, and Ocal.9-11 Barker assessed the
influence of homocysteine levels in follicular fluid
in 52 infertile patients with polycystic ovary syn-
drome (PCOS) underwent IVF program. The homo-
cysteine levels in follicular fluid, oocyte, and em-
bryo quality were then measured. The study, which
includes 94 follicles, higher levels of homocysteine
reduced the quality of oocytes and embryos. A
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similar study conducted by Ocal also showed a
negative correlation between homocysteine levels
with the pregnancy rates in IVF program.11 Mean
follicular fluid homocysteine levels in patients with
PCOS in Ocal’s study was higher than current study.
Thus, there is an estimation that homocysteine has
a treshold to give a negative effect on the oocytes
quality. However, there is still no recent study
which can determine the treshold level.
In Boxmeer study,10 the levels of homocysteine
in follicular fluid of infertile women who were gi-
ven supplements and without any supplementa-
tion was assessed and its influence in embryo qual-
ity was determined. The results showed that mean
levels of homocysteine in the group given supple-
ments were lower compared to the group without
supplementation. An interesting finding of this re-
search was that there is a negative correlation be-
tween homocysteine levels with embryo quality in
the group without the supplement, whereas in
group which supplement were given there was a
positive correlation, that means, high level of ho-
mocysteine in the group does not affect the quality
of oocytes. From these results, it was thought that
there must be an optimal homocysteine level
needed in the follicular micro-environment. Homo-
cysteine causes an increase level of reactive oxygen
species (ROS) and leads to oxidative stress, but the
value of the physiological or normal ROS is still re-
quired for oocyte maturation, ovulation and fertili-
zation.
In our study, all subjects in both groups were
given folic acid supplements during their IVF pro-
gram. This is the basic reason of why homocysteine
level in follicular fluid does not affect the oocyte
quality.
Correlation between homocysteinein the
plasma levels and in follicular fluid
Increased cytokines in the peritoneal cavity caused
by the endometriosis lesions has also added the
systemic inflammation mediators, such as C-reac-
tive protein (CRP), tumor necrosis factor-α (TNFα),
monocyte chemo-attractant protein-1 (MCP-1), in-
terleukin-6 (IL-6), and IL-8 in the peripheral blood
flow in patients with endometriosis. This fact re-
ferred that endometriosis is a local disease with
subclinical systemic manifestations.8 Increased ho-
mocysteine levels in blood plasma is also assumed
to have a similar mechanism as mentioned, that the
inflammation mediators has triggered the local and
systemic inflammation. Furthermore, the level of
homocysteine in plasma has a positive significant
correlation with those in follicular fluid. These find-
ings strengthen the idea that inflammation occur-
red in the peritoneum due to endometriosis lesions
affects the increase of systemic inflammation me-
diators.
Limitation of the study
The limitation of this study is that most of all sub-
jects were included based on the past surgical his-
tory resulting an endometriotic lesions by laparo-
tomy or laparoscopy. There are two subjects who
were included in the infertility with endometriosis
group only based on the clinical examination and
ultrasonography, because on inspection we found
suspected endometriosis lesions. The ovarian sti-
mulation mostly used the antagonist protocol, and
only three patients in the endometriosis group
with infertility used the agonist protocol. This stu-
dy did not distinguish the protocols used, because
no literature stated that stimulation protocols can
affect the levels of homocysteine in the blood plas-
ma and in follicular fluid. In our study, we only
measured levels of homocysteine in follicular fluid
from a single dominant follicle of each subject. This
method is thought to affect the mean levels of ho-
mocysteine in follicular fluid and oocyte quality as-
sessment. Oocytes other than the dominants, have-
poor quality, therefore they were not measured in
this study.
CONCLUSION
From this research we found the homocysteine
level in infertile with endometriosis women are
higher than without endometriosis. Homocysteine
level did not contribute the oocytes quality. There
were positive correlation between homocysteine
level in blood and follicular fluid in endometriosis
group.
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